Metastasis suppressor tetraspanin CD82/KAI1 regulates ubiquitylation of epidermal growth factor receptor

Elena Odintsova1, Guillaume van Niel2, Hélène Conjeaud3

  • 1From the School of Cancer Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham B15 2TT, United Kingdom,.

Insights

Tetraspanin CD82 suppresses the ubiquitylation of the epidermal growth factor receptor (EGFR) upon stimulation with specific ligands. This regulation impacts EGFR trafficking and signaling, revealing a new role for CD82 in controlling EGFR ubiquitylation.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Cancer Research

Background:

  • Epidermal growth factor receptor (EGFR) ubiquitylation is crucial for regulating its endocytic trafficking and signaling.
  • Tetraspanins are membrane proteins involved in various cellular processes, including receptor trafficking and signaling modulation.

Purpose of the Study:

  • To investigate the role of tetraspanin CD82 in the ubiquitylation and trafficking of EGFR.
  • To elucidate the molecular mechanisms by which CD82 influences EGFR regulation.

Main Methods:

  • Cell-based assays using CD82 expression and CD82 mutants.
  • Analysis of EGFR ubiquitylation, endocytosis, and phosphorylation.
  • Western blotting and immunofluorescence microscopy.

Main Results:

  • CD82 specifically suppresses EGFR ubiquitylation induced by heparin-binding EGF and amphiregulin.
  • CD82's suppressive effect is ligand-dependent and requires its C-terminal cytoplasmic domain.
  • CD82 influences EGFR recruitment to EEA1-positive endosomes and increases EGFR phosphorylation at Thr654.
  • CD82 upregulates PKC-dependent serine phosphorylation of c-Cbl.

Conclusions:

  • CD82 acts as a novel regulator of EGFR ubiquitylation and endocytic trafficking.
  • CD82 discriminatively controls the E3 ubiquitin ligase activity of c-Cbl towards specific EGFR-ligand complexes.
  • These findings highlight a previously unrecognized link between tetraspanins and the ubiquitylation machinery.

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...